Tapewire

Nasdaq · USD

BLFS

BIOLIFE SOLUTIONS INC

Export transactions ↓
Tapewire entity
4614
SEC CIK
0000834365
Parsed reports
1,001

Last 12 months

Inside the activity.

0 purchase rows · 39 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 202508
Jan 202605
Feb 202600
Mar 202609
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 10, 2022 Filed Feb 15, 2022 01:03 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 254 $29.38 $7,462.52
Disclosure

SEC source: 0001437749-22-003346 · rdgdoc.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,893

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:02 UTC
Aebersold SarahVP, Global Human Resources
SaleCommon Stock 197 $29.38 $5,787.86
Disclosure

SEC source: 0001437749-22-003345 · rdgdoc.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · VP, Global Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,039

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:02 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 293 $29.38 $8,608.34
Disclosure

SEC source: 0001437749-22-003344 · rdgdoc.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,527

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:02 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 690 $29.38 $20,272.20
Disclosure

SEC source: 0001437749-22-003343 · rdgdoc.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258,765

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:01 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 450 $29.38 $13,221.00
Disclosure

SEC source: 0001437749-22-003342 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,564

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
February 03, 2022 Filed Feb 5, 2022 01:12 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 9,837 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001437749-22-002543 · rdgdoc.xml · derivative · entry 6

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,000

Underlying: Common Stock · 9,837 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
February 03, 2022 Filed Feb 5, 2022 01:12 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 9,837 $27.76 $273,075.12
Disclosure

SEC source: 0001437749-22-002543 · rdgdoc.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,014

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of September 7, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.34 to $28.44, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 03, 2022 Filed Feb 5, 2022 01:12 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 9,837 $2.06 $20,264.22
Disclosure

SEC source: 0001437749-22-002543 · rdgdoc.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 03, 2022 Filed Feb 8, 2022 01:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionEmployee Stock Option · Derivative 16,670 $0.00 Strike: $1.78 $0.00
Disclosure

SEC source: 0001437749-22-002647 · rdgdoc.xml · derivative · entry 3

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,670 shares

Expires 2022-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On February 07, 2017, the reporting person was granted an option to purchase 100,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
February 03, 2022 Filed Feb 8, 2022 01:00 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 16,670 $27.84 $464,092.80
Disclosure

SEC source: 0001437749-22-002647 · rdgdoc.xml · nonDerivative · entry 2

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,455

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of December 1, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.35 to $28.43, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 03, 2022 Filed Feb 8, 2022 01:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionCommon Stock 16,670 $1.78 $29,672.60
Disclosure

SEC source: 0001437749-22-002647 · rdgdoc.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,125

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 02, 2022 Filed Feb 5, 2022 01:12 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $3.70 $0.00
Disclosure

SEC source: 0001437749-22-002543 · rdgdoc.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2024-04-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On April 21, 2014, the reporting person was granted an option to purchase 10,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
February 02, 2022 Filed Feb 5, 2022 01:12 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $29.88 $298,800.00
Disclosure

SEC source: 0001437749-22-002543 · rdgdoc.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,014

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of September 7, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.49 to $30.48, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 02, 2022 Filed Feb 5, 2022 01:12 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $3.70 $37,000.00
Disclosure

SEC source: 0001437749-22-002543 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,014

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2022 Filed Feb 4, 2022 02:31 UTC
Rice MichaelDirector · CEO
Exercise / conversionEmployee Stock Option · Derivative 16,666 $0.00 Strike: $1.78 $0.00
Disclosure

SEC source: 0001437749-22-002428 · rdgdoc.xml · derivative · entry 3

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,670

Underlying: Common Stock · 16,666 shares

Expires 2022-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On February 07, 2017, the reporting person was granted an option to purchase 100,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
February 01, 2022 Filed Feb 4, 2022 02:31 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 16,666 $29.90 $498,313.40
Disclosure

SEC source: 0001437749-22-002428 · rdgdoc.xml · nonDerivative · entry 2

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,455

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of December 1, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.31 to $30.54, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 01, 2022 Filed Feb 4, 2022 02:31 UTC
Rice MichaelDirector · CEO
Exercise / conversionCommon Stock 16,666 $1.78 $29,665.48
Disclosure

SEC source: 0001437749-22-002428 · rdgdoc.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,121

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 20, 2022 Filed Jan 25, 2022 02:07 UTC
Aebersold SarahVP, Global Human Resources
SaleCommon Stock 332 $30.24 $10,039.68
Disclosure

SEC source: 0001437749-22-001524 · rdgdoc.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · VP, Global Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,236

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
January 20, 2022 Filed Jan 25, 2022 02:07 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 395 $30.24 $11,944.80
Disclosure

SEC source: 0001437749-22-001523 · rdgdoc.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,391

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
January 12, 2022 Filed Jan 13, 2022 01:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionEmployee Stock Option · Derivative 16,666 $0.00 Strike: $1.78 $0.00
Disclosure

SEC source: 0001437749-22-000824 · rdgdoc.xml · derivative · entry 6

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,336

Underlying: Common Stock · 16,666 shares

Expires 2022-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On February 07, 2017, the reporting person was granted an option to purchase 100,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
January 12, 2022 Filed Jan 13, 2022 01:00 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 16,666 $31.72 $528,645.52
Disclosure

SEC source: 0001437749-22-000824 · rdgdoc.xml · nonDerivative · entry 4

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,455

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of December 1, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.17 to $32.19, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 12, 2022 Filed Jan 13, 2022 01:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionCommon Stock 16,666 $1.78 $29,665.48
Disclosure

SEC source: 0001437749-22-000824 · rdgdoc.xml · nonDerivative · entry 3

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,121

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 12, 2022 Filed Jan 14, 2022 01:00 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 267 $32.18 $8,592.06
Disclosure

SEC source: 0001437749-22-000889 · rdgdoc.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,786

F1 · shares: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
January 10, 2022 Filed Jan 13, 2022 01:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionEmployee Stock Option · Derivative 16,666 $0.00 Strike: $1.78 $0.00
Disclosure

SEC source: 0001437749-22-000824 · rdgdoc.xml · derivative · entry 5

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,002

Underlying: Common Stock · 16,666 shares

Expires 2022-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On February 07, 2017, the reporting person was granted an option to purchase 100,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
January 10, 2022 Filed Jan 13, 2022 01:00 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 16,666 $30.83 $513,812.78
Disclosure

SEC source: 0001437749-22-000824 · rdgdoc.xml · nonDerivative · entry 2

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,455

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of December 1, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.67 to $31.53, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 10, 2022 Filed Jan 13, 2022 01:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionCommon Stock 16,666 $1.78 $29,665.48
Disclosure

SEC source: 0001437749-22-000824 · rdgdoc.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,121

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 07, 2022 Filed Jan 12, 2022 01:00 UTC
DE GREEF RODERICKCOO & President
SaleCommon Stock 567 $30.75 $17,435.25
Disclosure

SEC source: 0001437749-22-000745 · rdgdoc.xml · nonDerivative · entry 3

DE GREEF RODERICK · CIK 0001241181 · COO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,812

F1 · kind: The sale reported herein was made by to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
January 07, 2022 Filed Jan 12, 2022 01:00 UTC
DE GREEF RODERICKCOO & President
SaleCommon Stock 2,053 $30.75 $63,129.75
Disclosure

SEC source: 0001437749-22-000745 · rdgdoc.xml · nonDerivative · entry 2

DE GREEF RODERICK · CIK 0001241181 · COO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,379

F1 · kind: The sale reported herein was made by to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
January 07, 2022 Filed Jan 12, 2022 01:00 UTC
DE GREEF RODERICKCOO & President
SaleCommon Stock 8,196 $30.75 $252,027.00
Disclosure

SEC source: 0001437749-22-000745 · rdgdoc.xml · nonDerivative · entry 1

DE GREEF RODERICK · CIK 0001241181 · COO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,432

F1 · kind: The sale reported herein was made by to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
January 07, 2022 Filed Jan 12, 2022 01:00 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 47 $30.75 $1,445.25
Disclosure

SEC source: 0001437749-22-000744 · rdgdoc.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,075

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
January 07, 2022 Filed Feb 18, 2022 01:26 UTC Amendment
Wichterman TroyChief Financial Officer
SaleCommon Stock 47 $30.75 $1,445.25
Disclosure

SEC source: 0001437749-22-003761 · rdgdoc.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,075

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

F2 · acquired: On January 11, 2022, the reporting person filed a Form 4 which inadvertently reported in Column 4 of Table I that the sale to cover transaction was an acquisition of securities rather than a disposition of securities. In fact, as reported in this amendment, the reporting person disposed of those shares.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 01:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 7,857 $0.00 Strike: $1.40 $0.00
Disclosure

SEC source: 0001437749-22-000565 · rdgdoc.xml · derivative · entry 6

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,857 shares

Expires 2022-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On February 15, 2012, the reporting person was granted an option to purchase 17,857 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 01:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 7,857 $34.30 $269,495.10
Disclosure

SEC source: 0001437749-22-000565 · rdgdoc.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,014

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of September 7, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.10 to $35.46, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 01:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 7,857 $1.40 $10,999.80
Disclosure

SEC source: 0001437749-22-000565 · rdgdoc.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,871

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 04, 2022 Filed Jan 7, 2022 01:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $1.40 $0.00
Disclosure

SEC source: 0001437749-22-000565 · rdgdoc.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,857

Underlying: Common Stock · 10,000 shares

Expires 2022-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On February 15, 2012, the reporting person was granted an option to purchase 17,857 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
January 04, 2022 Filed Jan 7, 2022 01:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $35.06 $350,600.00
Disclosure

SEC source: 0001437749-22-000565 · rdgdoc.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,014

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of September 7, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.59 to $35.33, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 04, 2022 Filed Jan 7, 2022 01:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $1.40 $14,000.00
Disclosure

SEC source: 0001437749-22-000565 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,014

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 29, 2021 Filed Dec 31, 2021 01:04 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 736 $39.37 $28,976.32
Disclosure

SEC source: 0001437749-21-029534 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,014

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 29, 2021 Filed Dec 31, 2021 01:02 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 928 $39.37 $36,535.36
Disclosure

SEC source: 0001437749-21-029532 · rdgdoc.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,455

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 29, 2021 Filed Dec 31, 2021 01:03 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 625 $39.37 $24,606.25
Disclosure

SEC source: 0001437749-21-029533 · rdgdoc.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,820

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 29, 2021 Filed Dec 31, 2021 01:01 UTC
DE GREEF RODERICKCOO & President
SaleCommon Stock 705 $39.37 $27,755.85
Disclosure

SEC source: 0001437749-21-029531 · rdgdoc.xml · nonDerivative · entry 1

DE GREEF RODERICK · CIK 0001241181 · COO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,628

F1 · kind: The sale reported herein was made by to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 29, 2021 Filed Dec 31, 2021 01:00 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 517 $39.37 $20,354.29
Disclosure

SEC source: 0001437749-21-029530 · rdgdoc.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,147

F1 · kind: The sale reported herein was made by to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 22, 2021 Filed Dec 24, 2021 01:00 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 310 $38.49 $11,931.90
Disclosure

SEC source: 0001437749-21-029225 · rdgdoc.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,122

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 22, 2021 Filed Feb 18, 2022 01:28 UTC Amendment
Wichterman TroyChief Financial Officer
SaleCommon Stock 310 $38.49 $11,931.90
Disclosure

SEC source: 0001437749-22-003762 · rdgdoc.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,122

F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

F2 · acquired: On December 23, 2021, the reporting person filed a Form 4 which inadvertently reported in Column 4 of Table I that the sale to cover transaction was an acquisition of securities rather than a disposition of securities. In fact, as reported in this amendment, the reporting person disposed of those shares.

Read SEC document
December 15, 2021 Filed Dec 16, 2021 01:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionEmployee Stock Option · Derivative 16,666 $0.00 Strike: $1.78 $0.00
Disclosure

SEC source: 0001437749-21-028681 · rdgdoc.xml · derivative · entry 6

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,668

Underlying: Common Stock · 16,666 shares

Expires 2022-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On February 07, 2017, the reporting person was granted an option to purchase 100,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
December 15, 2021 Filed Dec 16, 2021 01:00 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 16,666 $32.80 $546,644.80
Disclosure

SEC source: 0001437749-21-028681 · rdgdoc.xml · nonDerivative · entry 4

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,383

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of December 1, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.12 to $33.71, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2021 Filed Dec 16, 2021 01:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionCommon Stock 16,666 $1.78 $29,665.48
Disclosure

SEC source: 0001437749-21-028681 · rdgdoc.xml · nonDerivative · entry 3

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 277,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2021 Filed Dec 16, 2021 01:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionEmployee Stock Option · Derivative 16,666 $0.00 Strike: $1.78 $0.00
Disclosure

SEC source: 0001437749-21-028681 · rdgdoc.xml · derivative · entry 5

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,334

Underlying: Common Stock · 16,666 shares

Expires 2022-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On February 07, 2017, the reporting person was granted an option to purchase 100,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
December 13, 2021 Filed Dec 16, 2021 01:00 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 16,666 $33.82 $563,644.12
Disclosure

SEC source: 0001437749-21-028681 · rdgdoc.xml · nonDerivative · entry 2

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,383

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of December 1, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.98 to $34.51, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 13, 2021 Filed Dec 16, 2021 01:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionCommon Stock 16,666 $1.78 $29,665.48
Disclosure

SEC source: 0001437749-21-028681 · rdgdoc.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 277,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.